Bausch + Lomb Corp - SIC # 3851 - OPHTHALMIC GOODS

Ticker Exchange SIC # Website Latest Ticker
BLCO New York 3851 https://ir.bausch.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bausch + Lomb Corp

Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes - Apr 25th, 2024 12:30 pm
Bausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programs - Apr 18th, 2024 11:00 am
Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1 - Apr 15th, 2024 4:00 pm
Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting - Mar 27th, 2024 11:00 am
Bausch + Lomb Announces Appointment of Karen L. Ling to Board of Directors - Feb 28th, 2024 1:00 pm
Bausch + Lomb Corporation (NYSE:BLCO) Yearly Results: Here's What Analysts Are Forecasting For This Year - Feb 24th, 2024 12:40 pm
Bausch + Lomb Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags - Feb 23rd, 2024 10:40 am
Q4 2023 Bausch + Lomb Corp Earnings Call - Feb 22nd, 2024 3:35 am
Bausch & Lomb Corp (BLCO) Reports Robust Revenue Growth Amidst Net Loss in Q4 and Full-Year 2023 - Feb 21st, 2024 12:31 pm
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO - Feb 21st, 2024 12:00 pm
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 Guidance - Feb 21st, 2024 11:58 am
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2023 Financial Results on February 21 - Feb 5th, 2024 5:00 pm
Bausch + Lomb Receives FDA Approval for TENEO™ Excimer Laser Platform for Myopia and Myopic Astigmatism LASIK Vision Correction Surgery - Jan 8th, 2024 11:59 am
Bausch + Lomb to Participate in the 42nd Annual J.P. Morgan Healthcare Conference - Jan 3rd, 2024 2:00 pm
Is Bausch + Lomb Corporation (NYSE:BLCO) Trading At A 39% Discount? - Nov 21st, 2023 2:05 pm
Bausch + Lomb Reports More Than 76 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs - Nov 15th, 2023 11:59 am
Bausch & Lomb Corp (BLCO) Reports Q3 2023 Earnings and Raises Full-Year Guidance - Nov 1st, 2023 1:21 pm
Bausch + Lomb Announces Third-Quarter 2023 Results and Raises Full-Year 2023 Guidance - Nov 1st, 2023 10:58 am
Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Ophthalmology Annual Meeting - Oct 26th, 2023 10:59 am
Bausch + Lomb Will Release Third-Quarter 2023 Financial Results on November 1 - Oct 16th, 2023 4:00 pm